- Home
- ESEA vs ITOS Comparison
ESEA vs ITOS Comparison
Compare ESEA & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- ITOS
- Stock Information
- Founded
- ESEA 2005
- ITOS 2011
- Country
- ESEA Greece
- ITOS United States
- Employees
- ESEA N/A
- ITOS N/A
- Industry
- ESEA Marine Transportation
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESEA Consumer Discretionary
- ITOS Health Care
- Exchange
- ESEA Nasdaq
- ITOS Nasdaq
- Market Cap
- ESEA 253.9M
- ITOS 280.6M
- IPO Year
- ESEA 2006
- ITOS 2020
- Fundamental
- Price
- ESEA $33.01
- ITOS $8.00
- Analyst Decision
- ESEA Buy
- ITOS Strong Buy
- Analyst Count
- ESEA 1
- ITOS 3
- Target Price
- ESEA $53.00
- ITOS $21.33
- AVG Volume (30 Days)
- ESEA 49.1K
- ITOS 470.7K
- Earning Date
- ESEA 02-19-2025
- ITOS 03-05-2025
- Dividend Yield
- ESEA 7.27%
- ITOS N/A
- EPS Growth
- ESEA 3.12
- ITOS N/A
- EPS
- ESEA 16.28
- ITOS N/A
- Revenue
- ESEA $208,648,067.00
- ITOS $35,000,000.00
- Revenue This Year
- ESEA $14.91
- ITOS $271.18
- Revenue Next Year
- ESEA $7.13
- ITOS N/A
- P/E Ratio
- ESEA $2.03
- ITOS N/A
- Revenue Growth
- ESEA 13.90
- ITOS N/A
- 52 Week Low
- ESEA $31.14
- ITOS $7.09
- 52 Week High
- ESEA $50.92
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- ESEA 35.46
- ITOS 53.50
- Support Level
- ESEA $33.80
- ITOS $7.63
- Resistance Level
- ESEA $34.70
- ITOS $8.09
- Average True Range (ATR)
- ESEA 1.24
- ITOS 0.30
- MACD
- ESEA -0.03
- ITOS 0.06
- Stochastic Oscillator
- ESEA 4.55
- ITOS 74.11
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.